David Johnson of Fayetteville tells ABC11 he has a lot to live for. That's why he says he's grateful his doctors caught his prostate cancer early back in 2005. Due to the diagnosis, he says he had to have his prostate removed. After that, Johnson says he's mostly been healthy and able to enjoy life with his big, beautiful family ever since.

Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in situ, according to a recent article.

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of California Los Angeles and the Veterans Affairs (VA) National Precision Oncology Program found key differences in tumor biology between non-Hispanic Black and non-Hispanic white veterans,

Philadelphia, May 12, 2025 – New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment ... provide crucial insights into disease ...

Quoc-Dien Trinh, MD, MBA, discusses a sub-analysis of the phase 3 ARANOTE trial, which focused on Black patients with metastatic hormone-sensitive prostate cancer.